Hernia Mesh Devices Market Size, Share, Forecast and Outlook (2024-2031)

Global Hernia Mesh Devices Market is segmented By Hernia Type (Inguinal Hernia, Incisional Hernia, Umbilical Hernia, Femoral Hernia, Hiatal Hernia, Others) By Product Type (Synthetic Mesh, Absorbable, Non-absorbable, Hybrid, Animal-derived Mesh) By Mesh Size (15 cm x 9 cm, 15 cm x 10 cm) By End User (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Report Overview

Hernia Mesh Devices Market is expected to reach a CAGR of 3.2% during the forecast period 2024-2031

Hernia mesh is placed surgically near the lumpy area to repair the weakened muscle and the hernia. It is a thin, porous, woven material made up of biological, synthetic materials that provide strength and structure to damaged tissue during surgical procedures. 

Inguinal hernias are the most common type of hernia in the groin area, where healthcare professionals place and repair the mesh. Inguinal hernias occur between 10 and 15 percent of males and 2 percent of women during their lifetimes.

Market Scope

For more details on this report – Request for Sample

Market Dynamics: Drivers & Restraints

Increasing incidence of hernia repair surgeries

Hernia occurs when the internal organs protrude through a weak area in the muscular wall of the abdomen. This gives rise to an abnormal bulge under the stomach's skin, usually near the skin. Hernia mesh devices are placed at the groin or naval area so that the organs' lumps and stress on the muscle are repaired. The prevalence of hernia and hernia repair surgeries is increasing worldwide.

For instance, according to the Us Food and Drug Administration, 2023, an estimated 1 million inguinal hernia repairs are performed yearly in the US. These surgeries are estimated at nearly 20 million a year, making hernia repair surgeries one of the most commonly performed general surgery procedures worldwide. 

According to the American Academy of Pediatrics, 2023, the incidence of inguinal hernias is nearly 8 to 50 per 1000 live births, increasing to approximately 20% in deficient birth weight infants.

Furthermore, according to the International Journal of Medical Sciences, 2023, the prevalence is 4.36% in the Americas, 4.06% in Europe, and 4.88% in Southeast Asia. Men reported a much higher lifetime prevalence of inguinal hernias (20-27%) than women (3-6%).

Hernia recurrences with surgeries using mesh

Recurrent inguinal hernia is observed in many patients after the hernia is repaired. Even after the best surgical technique and measures, hernia recurrence is seen after placing a mesh due to many reasons like improper mesh placement, mesh absorption, etc. The recurrence rates were 8.2 percent after suture repair and 2.7 percent after mesh repair. The recurrence also depends upon the mesh material used. According to Baylor College of Medicine, 2023, studies have shown that up to 30% of hernia repairs can result in a recurrence.

Market Segment Analysis

The global hernia mesh devices are segmented based on hernia type, product type, mesh size, end user and region.

The Synthetic mesh segment accounted for approximately 43.3% of the market share

The synthetic mesh is expected to hold the largest segment due to its wide application in hernia repair surgeries. Synthetic meshes are either permanent, as in the case of nonabsorbable, or temporary, as absorbable. It is made up of materials like polyester, polypropylene, etc. 

These are the most common types of materials used in hernia surgeries. Product launch with advancements brings more efficacy to the procedure performed on the patient suffering from a hernia. 

For instance, in April 2022, Ariste Medical, LLC, a pre-commercial drug & device company, received FDA approval for its drug-embedded, synthetic hernia mesh in the United States to reduce microbial infections during surgical implantation.

In February 2022, Futura Surgicare Pvt. Ltd., an Indian-based medical device manufacturer, has recently introduced a range of surgical meshes under its brand Dolphin Mesh. These tension-free dual surgical meshes can be used for laparoscopic tension-free hernia repairs..

Market Geographical Analysis

North America accounted for approximately 40.2% of the market share in 2022

North America is expected to hold the largest market share due to the rising prevalence of hernia cases and surgeries among the U.S. population. For instance, according to the Cleveland Clinic Organisation, hiatal hernias affect around 20% of people in the U.S. and 50% over 50.

For instance, according to Springer Nature Journal, in the United States alone, 500,000 and 750,000 patients are operated on for inguinal hernias annually. 

Additionally, around 90% of hernia surgeries annually in the U.S. use hernia mesh. Usually, there are no causes or symptoms of hernia. A lump can be seen protruding from the stomach area, abdomen area, and groin area.

COVID-19 Impact Analysis

COVID-19 impacted the hernia mesh devices market due to the worldwide disruption in the supply chain. There is a shift in the focus of the research and development towards covid 19 vaccines and drugs. As lockdowns were implemented worldwide, the diagnostic procedures were postponed to later stages; hence, the surgeries were halted during COVID-19 unless they were essential. This has impacted the hernia meshes as the devices are not used for treatment. The number of hospital visits has drastically decreased during the period, and hence, most of the diagnostic centers did not prioritize hernia repairs.

Competitive Landscape

The major global players in the hernia mesh devices market include Medtronic plc, C. R. Bard Inc., Ethicon Inc., Atrium Medical Technologies, W. L. Gore & Associates, Inc., B. Braun Melsungen AG, LifeCell Corporation, Baxter International, Inc, Cook Medical Incorporated, Herniamesh S.r.l among others.

Key Developments

• In June 2023, Advanced Medical Solutions Group plc received US Food and Drug Administration approval for the use of LiquiBandFix8 to to fix mesh to tissue inside the body during inguinal hernia surgery. It has also been approved for closing the peritoneum, a membrane that surrounds the abdominal cavity.  
• In May 2023, Tissium, a tissue reconstruction company, secured $53.8m to launch its tissue repair platform and to commercialize other products that are in the pipeline, nerve repair, hernia repair, and cardiovascular sealants.

Why Purchase the Report?

• To visualize the global hernia mesh devices market segmentation based on hernia type, product type, mesh size, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development. 
• Excel data sheet with numerous data points of hernia mesh devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global hernia mesh devices market report would provide approximately 69 tables, 68 figures, and 190 Pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies